Immix Biopharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:IMMX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
22 Aug 24	BuyUS$51,623	Jason Hsu	Individual	23,100	US$2.25
16 Aug 24	BuyUS$18,600	Carey Ng	Individual	10,000	US$1.86
24 Jul 24	BuyUS$19,517	Jason Hsu	Individual	9,200	US$2.15
07 Jun 24	BuyUS$5,538	Ilya Rachman	Individual	2,600	US$2.13
07 Jun 24	BuyUS$5,298	Gabriel Morris	Individual	2,500	US$2.12
04 Jun 24	BuyUS$5,970	Ilya Rachman	Individual	3,300	US$1.81
04 Jun 24	BuyUS$5,973	Gabriel Morris	Individual	3,300	US$1.81
14 May 24	BuyUS$9,660	Ilya Rachman	Individual	4,300	US$2.25
14 May 24	BuyUS$10,042	Gabriel Morris	Individual	4,500	US$2.23

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMMX?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	3,915,913	14.2%
Institutions	5,982,348	21.7%
Individual Insiders	7,626,970	27.7%
General Public	9,982,406	36.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 38.5%.

Top Shareholders

Top 25 shareholders own 62.84% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
14.2%	Veritas Liberabit Vos, LLC	3,915,913	US$8.5m	0%	no data
11.8%	Yekaterina Chudnovsky	3,241,076	US$7.1m	0%	no data
4.13%	Ilya Rachman	1,136,259	US$2.5m	0%	no data
4.08%	Aigh Capital Management, LLC	1,123,663	US$2.4m	-20.1%	1.08%
3.73%	Mesa Verde Venture Partners	1,025,221	US$2.2m	0%	no data
3.29%	Vladimir Torchilin	905,200	US$2.0m	0%	no data
3.27%	Sean Senn	900,000	US$2.0m	0%	no data
3.25%	Jason Hsu	895,300	US$2.0m	3.74%	no data
3.09%	Bleichroeder LP	850,000	US$1.9m	0%	0.46%
2.89%	Cable Car Capital LLC	796,100	US$1.7m	0%	2.16%
2.54%	The Vanguard Group, Inc.	698,537	US$1.5m	16.7%	no data
1.47%	Lynwood Capital Management Inc.	405,000	US$882.9k	0%	6.68%
1.07%	Alwaysraise LLC	294,985	US$643.1k	0%	no data
1.04%	Gabriel Morris	285,834	US$623.1k	0%	no data
0.64%	Helen Adams	174,754	US$381.0k	0%	no data
0.55%	Geode Capital Management, LLC	150,082	US$327.2k	5.6%	no data
0.31%	Man Group Plc	85,000	US$185.3k	0%	0.03%
0.31%	Morgan Stanley, Investment Banking and Brokerage Investments	84,313	US$183.8k	44.2%	no data
0.31%	Royal Bank of Canada, Banking & Securities Investments	84,000	US$183.1k	63,100%	no data
0.17%	Magda Marquet	46,092	US$100.5k	0%	no data
0.16%	Tocqueville Asset Management LP	43,300	US$94.4k	14.6%	no data
0.16%	State Street Global Advisors, Inc.	42,960	US$93.6k	0%	no data
0.14%	Northern Trust Global Investments	38,914	US$84.8k	0%	no data
0.12%	Private Advisor Group, LLC	34,325	US$74.8k	-47.3%	no data
0.11%	Timber Point Capital Management LLC	30,000	US$65.4k	0%	0.42%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 04:00
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Immix Biopharma, Inc. is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Soo Romanoff	Edison Investment Research
Robert Burns	H.C. Wainwright & Co.
Jonathan Aschoff	Roth MKM